Fig. 6
From: CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker
Epigenetic modification of CD44 mediates dysfunctional T-cell phenotypes and poor prognoses of cancer cohorts. A The CD44 methylation levels (beta values) of tumor and normal tissues from TCGA database. B The correlation between CD44 methylation and cytotoxic T-cell levels (CTLs), dysfunctional T-cell phenotypes, and risk factors of TCGA cancer cohorts. C Overall survival curves of cancer groups with high methylation levels and those with low methylation levels of CD44